BioCentury
ARTICLE | Clinical News

AMT-021: Interim Phase I data

July 21, 2014 7:00 AM UTC

Interim data from an open-label, dose-ranging, Spanish Phase I trial in 8 patients with severe acute intermittent porphyria showed that a single IV injection of up to 2x10 13 genetic components/kg AMT...